Effect of Omega-3 Supplementation on Blood Pressure Regulation in Pregnant Women with Gestational Hypertension
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- The expected outcome of this study is that the combination of labetalol and omega-3 fatty acids will result in greater blood pressure reduction Systolic BP 5- 10mmHg; Diastolic BP 2- 6mmHg compared to labetalol alone (Systolic BP 5- 8mmHg; Diastolic BP 2- 4mmHg) in pregnant women with gestational hypertension
研究概览
简要总结
omega-3 supplements can help control high blood pressure in pregnant women with gestational hypertension.
Main Goal: To see if omega-3 fatty acids lower systolic and diastolic blood pressure compared to the standard drug treatment (labetalol).
Urinary nitrate levels – to measure how well the blood vessels work through nitric oxide availability.
C-reactive protein (CRP) levels – to track inflammation and its link with gestational hypertension.
In short, the research will compare blood pressure, vascular health, and inflammation between women taking omega-3 and those on labetalol to understand how effective omega-3 is in improving outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •40-year-old pregnant women. BP Greater Than or equal to 140 bar 90mmHg. After 20 weeks or 20-34 weeks of gestation. Singleton pregnancy. Newly diagnosed with HTN.
排除标准
- 未提供
结局指标
主要结局
The expected outcome of this study is that the combination of labetalol and omega-3 fatty acids will result in greater blood pressure reduction Systolic BP 5- 10mmHg; Diastolic BP 2- 6mmHg compared to labetalol alone (Systolic BP 5- 8mmHg; Diastolic BP 2- 4mmHg) in pregnant women with gestational hypertension
时间窗: One year
次要结局
未报告次要终点
研究者
Dr P Dhivyaprasth
Swamy Vivekanandha college of Pharmacy